A R T I C L E S
Key et al.
by crystal and solution NMR structures. In the MD simulations,
the HIF2R PAS-B protein populates both “open” and “closed”
conformers, with the closed form being preferred. We identified
ligand entry/exit pathways by observing routes taken by solvent
water being transferred to/from the ligand binding pocket. This
transfer takes place primarily in an open conformation of the
protein, although there is a minor route in the closed form. Taken
together, these data provide structural and energetic character-
izations of a protein that is apparently poised to bind natural or
artificial regulatory ligands and cofactors.
Figure 1. Crystal structures of HIF2R PAS-B reveal an internal solvent-
filled cavity that binds artificial ligands. (a) Crystal structure of the PAS B
domain of HIF2R in the apo form, showing the eight bound solvent atoms
within the core of the domain (red spheres). (b) Cutaway of the HIF-2R
surface that reveals the 290 Å3 internal cavity, depicted as a cyan-colored
surface.
Experimental Methods
Sample Preparation. 15N-labeled HIF2R PAS-B was purified
as described elsewhere.10 Briefly, an expression construct encoding
HIF2R PAS-B residues 240-350 was generated through PCR
amplification from cDNA ligated into the pHis6x-GB1 expression
plasmid.20 For ITC studies, protein was expressed in Luria broth,
while NMR studies utilized 15N-labeled protein as produced by
expression in M9 medium containing 15NH4Cl (1 g/L) as the sole
nitrogen source. Protein was purified by nickel chromatography and,
in bacteria and plants16 and assess energy content in bacteria,17
while heme-based PAS domains monitor dissolved gases.18
The sensory roles of many PAS domains, including those
from the HIF proteins, remain an open question, as they have
often been isolated without cofactors. Notably, recent structural
work on the HIF2R PAS-B domain shows that it contains a
290 Å3 water-filled cavity at its core, isolated from bulk solvent10
(Figure 1A,B). Cavities of this size are quite rare in proteins
and suggest a missing cofactor or ligand binding site.10 While
any natural HIF2R ligands remain unknown, we have discovered
a number of artificial ligands that bind within this site with low-
micromolar affinity using an NMR-based small-molecule
screen.19 Several of these compounds modulate the interaction
between HIF2R and ARNT PAS-B domains in vitro, suggesting
a linkage between internal ligand and external protein binding
on opposite faces of the central ꢀ-sheet of the protein, consistent
with PAS domains in other proteins.10,20-23 This raises the
question of how these ligands gain access to the internal cavity
of HIF2R PAS-B, which is completely inaccessible to solvent
in our structures.
To address this point and better understand the nature of HIF/
ligand interactions in general, we determined the crystal
structures of complexes of HIF2R PAS-B with two artificial
ligands bound at this internal site. These structural data
complement isothermal titration calorimetry (ITC) thermody-
namic studies of HIF2R PAS-B with these and three additional
ligands. Using NMR exchange spectroscopy, we determined the
association and dissociation rate constants for each of these
compounds and also, through their temperature dependence, the
transition-state thermodynamics of ligand binding. These pa-
rameters reflect the degree of protein conformational distortion
required to reach a ligand-accessible transition state. Finally,
we combined solution NMR studies and molecular dynamics
(MD) simulations to identify ligand entry/exit pathways to/from
the pocket of HIF2R PAS-B. The NMR-derived results suggest
that HIF2R PAS-B ligands bind rapidly to a partially disordered,
more open conformation of HIF2R PAS-B that must rapidly
interconvert with the ligand-inaccessible conformation illustrated
after cleavage of the N-terminal affinity tag by TEV protease,24
a
second round of nickel chromatography followed by Superdex 75
size-exclusion chromatography. For crystallization, PAS-B* mutants
of the HIF2R PAS-B (R247E) and ARNT PAS-B (E362R) domains
were produced as previously described.10
Crystallization and Structure Determination and Refinement.
Crystals of HIF2R PAS-B* were grown in a high-affinity het-
erodimer complex with the ARNT PAS-B* domain. Liganded
cocrystals were grown by vapor diffusion of 340 µM PAS-B*
heterodimer/440 µM compound solution against 100 mM Bis-Tris
(pH 6.0, 17-25% PEG-33500. Crystals were subsequently treated
with 25% PEG-3350 and 10% PEG-400 as a cryoprotectant prior
to freezing in liquid nitrogen. X-ray diffraction data were collected
at the 19-BM beamline of the Structural Biology Center at the
Advanced Photon Source (Argonne National Laboratory, Argonne,
IL). Data were reduced using HKL200025 and refined using
REFMAC 526 and COOT.27 Data scaling and refinement statistics
are summarized in Table 1. THS-017 cocrystals grew in the C2
space group reported previously10 and were amenable to Fourier
synthesis methods using the apoprotein structure (PDB entry 3F1P)
as an initial model. The THS-020 cocrystals adopted the P21 space
group, and the diffraction data were phased by molecular replace-
ment using the program PHASER.28 The experimental electron
densities for these two structures are shown in Supporting Informa-
tion (SI) Figure 1.
Determination of Ligand Binding Affinities. Ligand binding
affinities were determined using a MicroCal VP-ITC calorimeter
(Northampton, MA). Protein was extensively dialyzed against buffer
(25 mM Tris, pH 7.5, 17 mM NaCl, 5 mM ꢀ-mercaptoethanol),
which was used to prepare compound solutions from 50 mM stock
solutions in DMSO-d6. Solutions containing 200-330 µM HIF2R
PAS-B were titrated from the syringe of this instrument into a cell
containing 10-20 µM compound. Compound and protein solutions
all contained 0.02% DMSO, except for KG2-023, which was
supplemented with 5% DMSO to facilitate compound solubility
(minimal effects on thermodynamic parameters were observed in
5% DMSO controls with THS-017 and THS-020). Heats of dilution
were experimentally determined from control titrations of HIF2R
PAS-B into compound-free buffer and were subsequently subtracted
(15) Hoff, W. D.; Dux, P.; Hard, K.; Devreese, B.; Nugteren-Roodzant,
I. M.; Crielaard, W.; Boelens, R.; Kaptein, R.; van Beeumen, J.;
Hellingwerf, K. J. Biochemistry 1994, 33, 13959.
(16) Briggs, W. R. J. Biomed. Sci. 2007, 14, 499.
(17) Taylor, B. L. Mol. Microbiol. 2007, 65, 1415.
(24) Blommel, P. G.; Fox, B. G. Protein Expression Purif. 2007, 55, 53.
(25) Collaborative Computational Project, Number 4. Acta Crystallogr.,
Sect. D: Biol. Crystallogr. 1994, 50, 760.
(18) Gilles-Gonzalez, M. A.; Gonzalez, G. J. Biol. Chem. 1993, 268, 16293.
(19) Amezcua, C. A.; Harper, S. M.; Rutter, J.; Gardner, K. H. Structure
2002, 10, 1349.
(26) Murshudov, G. N.; Vagin, A. A.; Dodson, E. J. Acta Crystallogr.,
Sect. D: Biol. Crystallogr. 1997, 53, 240.
(20) Harper, S. M.; Neil, L. C.; Gardner, K. H. Science 2003, 301, 1541.
(21) Craven, C. J.; Derix, N. M.; Hendriks, J.; Boelens, R.; Hellingwerf,
K. J.; Kaptein, R. Biochemistry 2000, 39, 14392.
(27) Emsley, P.; Cowtan, K. Acta Crystallogr., Sect. D: Biol. Crystallogr.
2004, 60, 2126.
(22) Moglich, A.; Moffat, K. J. Mol. Biol. 2007, 373, 112.
(23) Gong, W.; Hao, B.; Chan, M. K. Biochemistry 2000, 39, 3955.
(28) McCoy, A. J.; Grosse-Kunstleve, R. W.; Adams, P. D.; Winn, M. D.;
Storoni, L. C.; Read, R. J. J. Appl. Crystallogr. 2007, 40, 658.
9
17648 J. AM. CHEM. SOC. VOL. 131, NO. 48, 2009